Avanos Medical Recalls CORFLO Safety PEG Kit
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Avanos Medical, Inc. is recalling 49 CORFLO Safety PEG Kits with ENFit Connector due to inclusion of supplier-recalled lidocaine hydrochloride injection.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on July 28, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets.
Which Products Are Affected
Product Name: CORFLO* Safety PEG Kit with ENFit¿ Connector Model/Catalog Number: 50-4320 UDI-DI: 10350770007578 Lot Numbers: 30365230, 30367013, 30373825 Quantity: 49 kits Distribution: US Nationwide distribution Recall Number: Z-2337-2026 Classification: Class II
What You Should Do
Consumers should refer to the recalling firm for further information regarding the affected lots.
Why This Matters
This ongoing Class II recall involves 49 kits distributed nationwide that contain a component subject to quality issues.
Source
FDA recall Z-2337-2026, Avanos Medical, Inc., Alpharetta, GA
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (778 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to July 28, 2026.
Frequently Asked Questions
Common questions about this FDA recall.